Eamonn Gardner

Cooley represented Sight Sciences (listed as SGHT on Nasdaq), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, which received a jury trial win on April 26, 2024, against its competitors – Alcon, Alcon Vision and Alcon Research (collectively known as Alcon) and Ivantis – in the US District Court for the District of Delaware.

Cooley achieved a significant victory for longtime client Qualcomm when US District Judge Paul G. Byron of the US District Court for the Middle District of Florida granted the firm’s motion for summary judgment in a contested patent infringement lawsuit, ParkerVision v. Qualcomm. Lawyers Stephen Smith, Matthew Brigham, Eamonn Gardner, Dena Chen, Jeffrey Karr, Priya Viswanath and Benjamin Lin led the Cooley team advising Qualcomm. Brigham and Gardner argued the motion for summary judgment, with assistance from the larger team.

Cooley advised fabless semiconductor developer Aquantia on its $70.6 million initial public offering of 7,840,700 shares of common stock, including the full exercise of the underwriters’ option to purchase additional shares.